Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Market valuation example

<< Previous

Bullboard Posts

Next >>

Comment by Infinityon Jun 09, 2022 2:00am

193 Views

Post# 34742574

RE:Market valuation example

Hey Sci-Fi, Thanks for the highlights of this. The median response duration is stated at 9.1 months. What happens after the response wears off. Does the turmor remain in the shrunken state or does it begin to grow or multiple..
Another question "20 of the 83 patients (24%) were continuing on treatment." I assume the reasoning could be that tumor could continue shrinking to a point that it disappears, or continuing the treatment could possibly prevent the turmor from grwoing in size again?

<< Previous

Bullboard Posts

Next >>

Golden Minerals closes Yoquivo gold-silver project sale